Aptose Biosciences Issues Non-Filed Information Disclosure - TipRanks.com - TipRanks
| APS Stock | CAD 0.33 0.03 8.33% |
About 62% of Aptose Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Aptose Biosciences suggests that many traders are alarmed. Aptose Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Aptose Biosciences. Many technical investors use Aptose Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aptose |
Aptose Biosciences Issues Non-Filed Information Disclosure - TipRanks.com TipRanks
Read at news.google.com
 |
Aptose Biosciences Fundamental Analysis
We analyze Aptose Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Aptose Biosciences is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Aptose Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptose Biosciences stock to make a market-neutral strategy. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics with similar companies.
Peers
Aptose Biosciences Related Equities
| BYD | Boyd Group | 0.84 | ||||
| FFH | Fairfax Financial | 0.37 | ||||
| WN | George Weston | 0.06 | ||||
| FSV | FirstService Corp | 0.08 | ||||
| TRI | Thomson Reuters | 0.26 | ||||
| WCN | Waste Connections | 0.49 | ||||
| WSP | WSP Global | 0.59 | ||||
| CSU | Constellation Software | 0.69 |
Check out Aptose Biosciences Hype Analysis, Aptose Biosciences Correlation and Aptose Biosciences Performance. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.